Captopril

卡托普利

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCaptopril
Drug Alias Name甲巯丙脯酸巯甲丙脯酸CaptorilCesplonCaptril +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzyme
Therapy Area/IndicationsSolid tumoursPostoperative ComplicationsLong Term Adverse Effects +[11] 
Global Approved IndicationsHypertensionMyocardial InfarctionHeart Failure +[4] 
Approved Indications in ChinaHypertensionHeart Failure
Original Approved Country/TerritoryJapan
Original Approved Date1980/01/01
Country/TerritoryUnited StatesEgyptMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChangzhou Pharmaceutical FactoryDaiichi Sankyo Co LtdAin Shams University
Inactive CompaniesAARXION ANDA Holdings LlcThe Brigham and Women's HospitalGlaxosmithkline Plc +[6] 
Active IndicationsHypertensionMyocardial InfarctionHeart Failure +[5] 
Inactive IndicationsSolid tumoursPostoperative ComplicationsLong Term Adverse Effects +[6] 

Other Information

ATC CodeC09AA01
Related LinksWikipediaDrugBankKEGG